University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients

dc.contributor.authorBurkill, Sarah
dc.contributor.authorPorsbjerg, Celeste M.
dc.contributor.authorBourdin, Arnaud
dc.contributor.authorTran, Trung N
dc.contributor.authorMartin, Neil
dc.contributor.authorKatial, Rohit
dc.contributor.authorBarker, Peter
dc.contributor.authorWechsler, Michael E
dc.contributor.authorMaspero, Jorge F
dc.contributor.authorBosnic-Anticevich, Sinthia
dc.contributor.authorChung, Li Ping
dc.contributor.authorKatsoulotos, Gregory
dc.contributor.authorChristoff, George
dc.contributor.authorPopov, Todor A
dc.contributor.authorSadatsafavi, Mohsen
dc.contributor.authorTorres-Duque, Carlos A.
dc.contributor.authorUlrik, Charlotte
dc.contributor.authorAssing, Karin Dahl
dc.contributor.authorHansen, Susanne
dc.contributor.authorAltraja, Alan
dc.contributor.authorLehtimäki, Lauri A.
dc.contributor.authorPapadopoulos, Nikolaos G
dc.contributor.authorKostikas, Konstantinos
dc.contributor.authorSalvi, Sundeep
dc.contributor.authorCostello, Richard W
dc.contributor.authorPuggioni, Francesca
dc.contributor.authorIwanaga, Takashi
dc.contributor.authorRhee, Chin Kook
dc.contributor.authorAl-Ahmad, Mona
dc.contributor.authorLarenas-Linnemann, Désirée
dc.contributor.authorFonseca, João A.
dc.contributor.authorAmaral, Rita
dc.contributor.authorAl-Lehebi, Riyad
dc.contributor.authorPerez de Llano, Luis
dc.contributor.authorKirenga, Bruce
dc.contributor.authorTsai, Ming-Ju
dc.contributor.authorMahboub, Bassam
dc.contributor.authorPfeffer, Paul E
dc.contributor.authorHenley, William
dc.contributor.authorLiu, Yang
dc.contributor.authorLyu, Juntao
dc.contributor.authorGoh, Celine
dc.contributor.authorUthaman, Thendral
dc.contributor.authorPrice, David
dc.contributor.authorISAR IGNITE
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2023-11-30T00:05:57Z
dc.date.available2023-11-30T00:05:57Z
dc.date.embargoedUntil2023-11-30
dc.date.issued2022-12-01
dc.descriptionFunding: This study was conducted by the Observational and Pragmatic Research Institute (OPRI) Pte Ltd and was partially funded by Optimum Patient Care Global and AstraZeneca Ltd. No funding was received by OPRI for its contribution.en
dc.description.statusPeer revieweden
dc.format.extent1
dc.format.extent296096
dc.identifier236864111
dc.identifier2b632753-798e-48c2-a87f-2a2d07e15cbb
dc.identifier.citationBurkill, S, Porsbjerg, C M, Bourdin, A, Tran, T N, Martin, N, Katial, R, Barker, P, Wechsler, M E, Maspero, J F, Bosnic-Anticevich, S, Chung, L P, Katsoulotos, G, Christoff, G, Popov, T A, Sadatsafavi, M, Torres-Duque, C A, Ulrik, C, Assing, K D, Hansen, S, Altraja, A, Lehtimäki, L A, Papadopoulos, N G, Kostikas, K, Salvi, S, Costello, R W, Puggioni, F, Iwanaga, T, Rhee, C K, Al-Ahmad, M, Larenas-Linnemann, D, Fonseca, J A, Amaral, R, Al-Lehebi, R, Perez de Llano, L, Kirenga, B, Tsai, M-J, Mahboub, B, Pfeffer, P E, Henley, W, Liu, Y, Lyu, J, Goh, C, Uthaman, T, Price, D & ISAR IGNITE 2022, 'Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients', European Respiratory Journal, vol. 60, no. 66, 3305. https://doi.org/10.1183/13993003.congress-2022.3305en
dc.identifier.doi10.1183/13993003.congress-2022.3305
dc.identifier.iss66en
dc.identifier.issn0903-1936
dc.identifier.urihttps://hdl.handle.net/2164/22295
dc.identifier.vol60en
dc.language.isoeng
dc.relation.ispartofEuropean Respiratory Journalen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleReal-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patientsen
dc.typeJournal itemen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Burkill_etal_ERS2022Real_Life_Biomarker_AAM.pdf
Size:
289.16 KB
Format:
Adobe Portable Document Format

Collections